Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis

K. Heschl (ZH, Switzerland), N. Haas-Baumann (ZH, Switzerland), R. Weber (ZH, Switzerland), A. Baghdasaryan (ZH, Switzerland), S. Micic (ZH, Switzerland), F. Singer (ZH, Switzerland), R. Zenobi (ZH, Switzerland), T. Bruderer (ZH, Switzerland), A. Möller (ZH, Switzerland)

Source: International Congress 2018 – Latest developments in cystic fibrosis

Session: Latest developments in cystic fibrosis
Session type: Poster Discussion
Number: 3411

Disease area: Paediatric lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Heschl (ZH, Switzerland), N. Haas-Baumann (ZH, Switzerland), R. Weber (ZH, Switzerland), A. Baghdasaryan (ZH, Switzerland), S. Micic (ZH, Switzerland), F. Singer (ZH, Switzerland), R. Zenobi (ZH, Switzerland), T. Bruderer (ZH, Switzerland), A. Möller (ZH, Switzerland). Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis. 3411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Distinct volatile markers from Cystic Fibrosis pathogens with Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
The value of rapid speciation of nontuberculous mycobacteria (NTM) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015
Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Late Breaking Abstract - Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry demonstrates inhaled drug deposition in transbronchial cryobiopsy samples of patients with Interstitial Lung Disease (ILD) Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019
Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020
Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008
Ion mobility spectrometry in lung transplant patients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
Comparison of the measurement of LCI and FRC by the NDD EasyOne ProLAB and mass spectrometry (MS) Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Linezolid penetrates in human pleural cavity: A pilot study using ultra-high pressure liquid chromatography in tandem with mass spectrometry (UPLC-MS/MS) Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011
Fat-Free Mass Index and functional limitation in COPD Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012
Modelling electronic nose sensor deflections by matching Gas Chromatography-Mass Spectrometry exhaled breath samples Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Methodological issues of sample collection and analysis of exhaled breath Source: Eur Respir Monogr 2010; 49: 96-114 Year: 2010
Expiratory gas analysis using mass spectrometry in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Real-time determination of slightly volatile amino acids in the exhalome by secondary electrospray ionization. A proof-of-principle study Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016
Development of mass spectrometry approaches to quantifying lipid mediators in airway disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017